环磷酰胺及其在管理暴露于口服双膦酸盐患者中的作用。 - Suppr

Suppr

超能文献

CTX and its role in managing patients exposed to oral bisphosphonates.

作者信息

Dodson Thomas B

出版信息

J Oral Maxillofac Surg. 2010 Feb;68(2):487-8; author reply 488-9. doi: 10.1016/j.joms.2009.07.088. Epub 2010 Jan 15.

DOI:10.1016/j.joms.2009.07.088

PMID:20116729

Abstract

摘要

相似文献

CTX and its role in managing patients exposed to oral bisphosphonates.

J Oral Maxillofac Surg. 2010 Feb;68(2):487-8; author reply 488-9. doi: 10.1016/j.joms.2009.07.088. Epub 2010 Jan 15.

Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

J Oral Maxillofac Surg. 2008 Jun;66(6):1320-1; author reply 1321-2. doi: 10.1016/j.joms.2008.01.054.

Serum CTX testing.

J Oral Maxillofac Surg. 2008 Jun;66(6):1319-20; author reply 1320. doi: 10.1016/j.joms.2007.12.048.

CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part I: biological concepts with a review of the literature.

Implant Dent. 2009 Dec;18(6):492-500. doi: 10.1097/ID.0b013e3181c6837c.

Osteonecrosis of the jaw and biomarkers: what do we tell our patients?

Int J Oral Maxillofac Implants. 2008 Mar-Apr;23(2):179-80.

Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis.

Int J Oral Maxillofac Implants. 2007 Jan-Feb;22(1):146-53.

Bisphosphonates--what the dentist needs to know: practical considerations.

J Oral Maxillofac Surg. 2009 May;67(5 Suppl):53-60. doi: 10.1016/j.joms.2009.01.011.

Serum CTX to prevent osteonecrosis/orthodontic extraction of third molars: paths toward minimizing surgical risk?

J Oral Maxillofac Surg. 2007 Dec;65(12):2395-6. doi: 10.1016/j.joms.2007.10.002.

Atraumatic extraction of a non-vital tooth in a patient receiving long-term oral bisphosphonates.

Northwest Dent. 2010 Jul-Aug;89(4):27-33.

Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.

J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7. doi: 10.1016/j.joms.2010.05.043.

引用本文的文献

Mechanism, prevention, and treatment for medication-related osteonecrosis of the jaws.

Hua Xi Kou Qiang Yi Xue Za Zhi. 2021 Jun 1;39(3):245-254. doi: 10.7518/hxkq.2021.03.001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

CTX and its role in managing patients exposed to oral bisphosphonates.

J Oral Maxillofac Surg. 2010 Feb;68(2):487-8; author reply 488-9. doi: 10.1016/j.joms.2009.07.088. Epub 2010 Jan 15.

Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

J Oral Maxillofac Surg. 2008 Jun;66(6):1320-1; author reply 1321-2. doi: 10.1016/j.joms.2008.01.054.

Serum CTX testing.

J Oral Maxillofac Surg. 2008 Jun;66(6):1319-20; author reply 1320. doi: 10.1016/j.joms.2007.12.048.

Implant Dent. 2009 Dec;18(6):492-500. doi: 10.1097/ID.0b013e3181c6837c.

Osteonecrosis of the jaw and biomarkers: what do we tell our patients?

Int J Oral Maxillofac Implants. 2008 Mar-Apr;23(2):179-80.

Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis.

Int J Oral Maxillofac Implants. 2007 Jan-Feb;22(1):146-53.

Bisphosphonates--what the dentist needs to know: practical considerations.

J Oral Maxillofac Surg. 2009 May;67(5 Suppl):53-60. doi: 10.1016/j.joms.2009.01.011.

Serum CTX to prevent osteonecrosis/orthodontic extraction of third molars: paths toward minimizing surgical risk?

J Oral Maxillofac Surg. 2007 Dec;65(12):2395-6. doi: 10.1016/j.joms.2007.10.002.

Atraumatic extraction of a non-vital tooth in a patient receiving long-term oral bisphosphonates.

Northwest Dent. 2010 Jul-Aug;89(4):27-33.

Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.

J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7. doi: 10.1016/j.joms.2010.05.043.

引用本文的文献

Mechanism, prevention, and treatment for medication-related osteonecrosis of the jaws.

Hua Xi Kou Qiang Yi Xue Za Zhi. 2021 Jun 1;39(3):245-254. doi: 10.7518/hxkq.2021.03.001.

CTX and its role in managing patients exposed to oral bisphosphonates.

作者信息

Dodson Thomas B

出版信息

J Oral Maxillofac Surg. 2010 Feb;68(2):487-8; author reply 488-9. doi: 10.1016/j.joms.2009.07.088. Epub 2010 Jan 15.

DOI:10.1016/j.joms.2009.07.088

PMID:20116729

Abstract

摘要